# Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable

- Link: https://www.thailand-business-news.com/pr-news/cambridge-heartwear-awarded-184-million-nhs-tender-for-worlds-first-medical-grade-wirelessly-charged-reusable-ecg-wearable-2
- Published: 2026-10-07T00:00:00+07:00
- Author: PR Newswire

CAMBRIDGE, England, Oct. 7, 2026 /PRNewswire/ — Cambridge Heartwear® Limited ([www.camheartwear.com](https://nam11.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.camheartwear.com%2F&data=05%7C02%7Crelease%40prnewswire.co.uk%7C4479d235687045f5ca6108df20c2f6e2%7C887bf9ee3c824b88bcb280d5e169b99b%7C1%7C0%7C639265693952517926%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=3%2BjiNY0cZKgihFIHSchyd2B4QEYVY1pvXYjK%2BlLCz64%3D&reserved=0))
has secured a landmark **£184 million tender** with the National Health Service (
NHS) of the UK for HeartSense®, the **world’s first medical-grade, multi-channel,
portable, wirelessly charged ECG wearable straight to one’s mobile phone**, representing
a significant advancement in global Medical technology, AI application and cardiovascular
diagnostics. 

[⌊Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-
Grade, Wirelessly Charged, Reusable ECG Wearable⌉⌊Cambridge Heartwear Awarded £184
Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable
ECG Wearable⌉[
Cambridge Heartwear Awarded £184 Million NHS Tender for World’s First
Medical-Grade, Wirelessly Charged, Reusable ECG Wearable

The agreement with the UK National Health Service Supply chain enables the deployment
of advanced cardiac monitoring technology across primary and secondary care and 
civil service departments, empowering patients to diagnose heart rhythm problems
whenever and wherever they are to prevent heart failure and strokes earlier, reduce
waiting times and support a more preventative approach to Heart Disease, which can
take place in the comfort of their own homes. 

HeartSense® is the world’s first wearable to combine diagnostic-grade multi-channel
ECG monitoring, adaptive artificial intelligence and wireless charging in a single
device. Manufactured to bridge the gap in women’s cardiovascular care with its ergonomic
design, the technology gives healthcare professionals and patients access to continuous,
real-time ECG data on a mobile phone. giving you back the control of your health
at every stage. 

Engineered in Cambridge and manufactured in Britain, HeartSense® has been developed
to help identify cardiovascular disease and stroke risk before conditions become
acute. Its proprietary engineering and AI technology with (86 patents ) support 
earlier intervention, enabling clinicians to make more informed decisions and improve
patient outcomes. 

The system is UKCA approved and ISO 13845 certified, with FDA 510(k) applications
currently in progress. 

"We did not have a UK ECG manufacturer and reporter until now," said Professor [Rameen Shakur](https://www.genomicsengland.co.uk/about-us/governance/profile/professor-rameen-shakur),
Founder of Cambridge Heartwear. "HeartSense® is the world’s first medical-grade,
AI-powered, multi-channel ECG wearable and demonstrates what can be achieved when
clinicians, engineers and AI specialists work together. We want to help move healthcare
towards earlier diagnosis, better prevention and improved outcomes for patients 
across the NHS." 

The partnership with the NHS Supply Chain allows Integrated Care Boards to deploy
HeartSense® at scale, supporting the delivery of diagnostic-quality heart monitoring
beyond hospital environments. The initiative is intended to reduce pressure on secondary
care services while improving access to high-quality cardiac diagnostics in community
settings. 

Founded by Professor [Rameen Shakur](https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.office.com%2Fsearch%3Fq%3DRameen%2BShakur%26EntityRepresentationId%3Dce607db1-d950-8c56-9370-0f8ee7d83c9d&data=05%7C02%7Crelease%40prnewswire.co.uk%7C4479d235687045f5ca6108df20c2f6e2%7C887bf9ee3c824b88bcb280d5e169b99b%7C1%7C0%7C639265693952575674%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=e2D8T0THykMRhNhfbGJKq8UHJVl0XiJthfJB%2FlJP6Dc%3D&reserved=0),
Cambridge Heartwear is a medical technology company based at Cambridge Science Park
coming out of the University of Cambridge dedicated to making heart health monitoring
simple, accessible and accurate. Combining medical research, engineering excellence
and artificial intelligence, the company develops advanced wearable technologies
that empower patients and healthcare professionals with diagnostic-quality cardiovascular
insights anytime, anywhere. HeartSense® helps detect heart conditions earlier, enabling
more informed clinical decision-making and better patient care.

Contact: [info@camheartwear.com](https://www.thailand-business-news.com/pr-news/info@camheartwear.com)

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable ](http://www.prnasia.com/story/archive/5057099_EN57099_0?rand=184833)